Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Germany (J.H., C.E.M., I.H.A.-T., M.T., Y.Z., S.D., A.S., S.N., D.D.).
Department of Cardiology, Cardiovascular Research Institute Maastricht, Faculty of Health, Medicine, and Life Sciences, Maastricht University, the Netherlands (J.H.).
Circ Res. 2023 Apr 28;132(9):e116-e133. doi: 10.1161/CIRCRESAHA.122.321858. Epub 2023 Mar 17.
Small-conductance Ca-activated K (SK)-channel inhibitors have antiarrhythmic effects in animal models of atrial fibrillation (AF), presenting a potential novel antiarrhythmic option. However, the regulation of SK-channels in human atrial cardiomyocytes and its modification in patients with AF are poorly understood and were the object of this study.
Apamin-sensitive SK-channel current (I) and action potentials were recorded in human right-atrial cardiomyocytes from sinus rhythm control (Ctl) patients or patients with (long-standing persistent) chronic AF (cAF).
I was significantly higher, and apamin caused larger action potential prolongation in cAF- versus Ctl-cardiomyocytes. Sensitivity analyses in an in silico human atrial cardiomyocyte model identified I and I as major regulators of repolarization. Increased I in cAF was not associated with increases in mRNA/protein levels of SK-channel subunits in either right- or left-atrial tissue homogenates or right-atrial cardiomyocytes, but the abundance of SK2 at the sarcolemma was larger in cAF versus Ctl in both tissue-slices and cardiomyocytes. Latrunculin-A and primaquine (anterograde and retrograde protein-trafficking inhibitors) eliminated the differences in SK2 membrane levels and I between Ctl- and cAF-cardiomyocytes. In addition, the phosphatase-inhibitor okadaic acid reduced I amplitude and abolished the difference between Ctl- and cAF-cardiomyocytes, indicating that reduced calmodulin-Thr80 phosphorylation due to increased protein phosphatase-2A levels in the SK-channel complex likely contribute to the greater I in cAF-cardiomyocytes. Finally, rapid electrical activation (5 Hz, 10 minutes) of Ctl-cardiomyocytes promoted SK2 membrane-localization, increased I and reduced action potential duration, effects greatly attenuated by apamin. Latrunculin-A or primaquine prevented the 5-Hz-induced I-upregulation.
I is upregulated in patients with cAF due to enhanced channel function, mediated by phosphatase-2A-dependent calmodulin-Thr80 dephosphorylation and tachycardia-dependent enhanced trafficking and targeting of SK-channel subunits to the sarcolemma. The observed AF-associated increases in I, which promote reentry-stabilizing action potential duration shortening, suggest an important role for SK-channels in AF auto-promotion and provide a rationale for pursuing the antiarrhythmic effects of SK-channel inhibition in humans.
小电导钙激活钾(SK)通道抑制剂在心房颤动(AF)的动物模型中具有抗心律失常作用,为新型抗心律失常提供了可能。然而,人类心房肌细胞中 SK 通道的调节及其在 AF 患者中的改变仍知之甚少,这是本研究的目的。
从窦性节律控制(Ctl)患者或持续性慢性 AF(cAF)患者的右心房心肌细胞中记录 Apamin 敏感的 SK 通道电流(I)和动作电位。
cAF 心肌细胞的 I 明显较高,Apamin 引起的动作电位延长也较大。在一个模拟的人类心房肌细胞模型中的敏感性分析表明,I 和 I 是复极的主要调节因子。cAF 中 I 的增加与右心房或左心房组织匀浆或右心房心肌细胞中 SK 通道亚基的 mRNA/蛋白水平增加无关,但在组织切片和心肌细胞中,cAF 中 SK2 的质膜含量大于 Ctl。Latrunculin-A 和 Primaquine(顺行和逆行蛋白转运抑制剂)消除了 Ctl 和 cAF 心肌细胞之间 SK2 膜水平和 I 的差异。此外,磷酸酶抑制剂 okadaic acid 降低了 I 幅度,并消除了 Ctl 和 cAF 心肌细胞之间的差异,表明由于 SK 通道复合物中蛋白磷酸酶 2A 水平升高导致的钙调蛋白 Thr80 磷酸化减少可能导致 cAF 心肌细胞中 I 的增加。最后,Ctl 心肌细胞的快速电激活(5 Hz,10 分钟)促进了 SK2 的膜定位,增加了 I,缩短了动作电位时程,Apamin 大大减弱了这些作用。Latrunculin-A 或 Primaquine 阻止了 5-Hz 诱导的 I 上调。
由于磷酸酶 2A 依赖性钙调蛋白 Thr80 去磷酸化和心动过速依赖性 SK 通道亚基向质膜的易位增强,导致功能增强,cAF 患者的 I 上调。观察到的与 AF 相关的 I 增加促进了折返稳定的动作电位时程缩短,表明 SK 通道在 AF 自动促进中起重要作用,并为在人类中探索 SK 通道抑制的抗心律失常作用提供了依据。